The potential role of microRNAs in lung allograft rejection

Journal of Heart and Lung Transplantation

Volumn 35, Issue 5, 2016, Pages 550-559

  Ladak, Shameem S ^a   Ward, Chris ^a   Ali, Simi ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

allograft rejection; biomarkers; BOS; fibrosis; microRNA

Indexed keywords

MICRORNA;

ALLOGRAFT; ARTICLE; BIOGENESIS; BRONCHIOLITIS OBLITERANS; CLINICAL TRIAL (TOPIC); DISEASE MARKER; EPITHELIAL MESENCHYMAL TRANSITION; GENE CONTROL; GENE IDENTIFICATION; GENE TARGETING; GENE THERAPY; GENETIC SCREENING; HEART TRANSPLANTATION; HUMAN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG DISEASE; LUNG DYSFUNCTION; LUNG FUNCTION; LUNG GRAFT REJECTION; LUNG INJURY; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; GRAFT REJECTION; LUNG TRANSPLANTATION;

ALLOGRAFTS; BRONCHIOLITIS OBLITERANS; GRAFT REJECTION; HUMANS; LUNG TRANSPLANTATION; MICRORNAS;

EID: 84968796773     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2016.03.018     Document Type: Article

References (107)

1. D.K.C. Cooper Transplantation of the heart and both lungs I. Historical review Thorax 24 1969 383 390
2. R.Y. Calne Clinical organ transplantation 1971 Wiley-Blackwell New York
3. J.B. Orens, and E.R.J. Garrity General overview of lung transplantation and review of organ allocation Proc Am Thorac Soc 6 2009 13 19
4. J. Gottlieb Update on lung transplantation Ther Adv Respir Dis 2 2008 237 247
5. M. Hartert, O. Senbaklavacin, B. Gohrbandt, and et al. Lung transplantation: a treatment option in end-stage lung disease Dtsch Arztebl Int 111 2014 107 116
6. M.I. Suwara, B.M. Vanaudenaerde, S.E. Verleden, and et al. Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation Transpl Int 27 2014 857 867
7. D. Hayes Jr A review of bronchiolitis obliterans syndrome and therapeutic strategies J Cardiothorac Surg 6 2011 92
8. S. Kesten, A. Maidenberg, T. Winton, and et al. Treatment of presumed and proven acute rejection following six months of lung transplant survival Am J Respir Crit Care Med 152 1991 1321 1324
9. I. Neuringer, A. Medaiyese, P. McNeillie, and et al. New insights into acute and chronic lung rejection Curr Respir Med Rev 4 2008 40 51
10. M.K. Song, A. De Vito Dabbs, S.M. Studer, and et al. Course of illness after the onset of chronic rejection in lung transplant recipients Am J Crit Care 17 2008 246 253
11. A. Holbro, T. Lehmann, S. Girsberger, and et al. Lung histology predicts outcome of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation Biol Blood Marrow Transplant 19 2013 973 980
12. A.A. Mangi, D.P. Mason, E.R. Nowicki, and et al. Predictors of acute rejection after lung transplantation Ann Thorac Surg 91 2011 1754 1762
13. K. Bando, I.L. Paradis, S. Similo, and et al. Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management J Thorac Cardiovasc Surg 110 1995 4 13
14. L.P. Nicod Mechanisms of airway obliteration after lung transplantation Proc Am Thorac Soc 3 2006 444 449
15. C. Ward, I.A. Forrest, D.M. Murphy, and et al. Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients Thorax 60 2005 865 871
16. F. Huyard, C. Yzydorczyk, M.M. Castro, and et al. Remodeling of aorta extracellular matrix as a result of transient high oxygen exposure in newborn rats: implication for arterial rigidity and hypertension risk PLoS One 9 2014 e92287
17. M. Sato, D.S. Shames, and Y. Hasegawa Emerging evidence of epithelial-to-mesenchymal transition in lung carcinogenesis Respirology 17 2012 1048 1059
18. H. Zhao, Y. Chan-Li, S.L. Collins, and et al. Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis BMC Pulm Med 14 2014 64
19. K.J. Greenlee, Z. Werb, and F. Kheradmand Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted Physiol Rev 87 2007 69 98
20. C. Egger, C. Gérard, N. Vidotto, and et al. Lung volume quantified by MRI reflects extracellular-matrix deposition and altered pulmonary function in bleomycin models of fibrosis: effects of SOM230 Am J Physiol Lung Cell Mol Physiol 306 2014 L1064 L1077
21. B.I. Jugdutt Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation 108 2003 1395 1403
22. J. Camara, and G. Jarai Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-alpha Fibrogen Tissue Repair 3 2010 2
23. S. Van Linthout, K. Miteva, and C. Tschope Crosstalk between fibroblasts and inflammatory cells Cardiovasc Res 102 2014 258 269
24. Q. Yu, and I. Stamenkovic Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis Genes Dev 14 2000 163 176
25. C. Vancheri, M. Failla, N. Crimi, and et al. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology Eur Respir J 35 2010 496 504
26. Willis BC, Borok Z. TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol. 2007;293:L525-34.
27. Ladak SS, Ali S, Ward C. The potential role of miRNA-200b in the development of Bronchiolitis obliterans syndrome. In Immunology (Vol. 143, pp. 171-171), New Jersey, Wiley-Blackwell; 2014.
28. C. Lino, L. Christian, N. Kaminski, and et al. Micromanaging microRNAs: using murine models to study microRNAs in lung fibrosis Drug Discov Today Dis Mod 10 2013 e145 e151
29. Q.Z. Wang, W. Xu, N. Habib, and et al. Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy Curr Cancer Drug Targets 9 2009 572 594
30. C.C. Pritchard, H.H. Cheng, and M. Tewari MicroRNA profiling: approaches and considerations Nat Rev Genet 13 2012 358 369
31. D. Lemons, M.R. Maurya, S. Subramaniam, and et al. Developing microRNA screening as a functional genomics tool for disease research Front Physiol 4 2013 223
32. B.P. Lewis, I.H. Shih, M.W. Jones-Rhoades, and et al. Prediction of mammalian microRNA targets Cell 115 2003 787 798
33. A.J. Enright, B. John, U. Gaul, and et al. MicroRNA targets in Drosophila Genome Biol 5 2003 R1
34. A. Krek, D. Grun, MN Poy, and et al. Combinatorial microRNA target predictions Nat Genet 37 2005 495 500
35. A. Shkumatava, A. Stark, H. Sive, and et al. Coherent but overlapping expression of microRNAs and their targets during vertebrate development Genes Dev 23 2009 466 481
36. D.W. Thomson, C.P. Bracken, and G.J. Goodall Experimental strategies for microRNA target identification Nucleic Acids Res 39 2011 6845 6853
37. S. Maltby, M. Plank, C. Ptaschinski, and et al. MicroRNA function in mast cell biology: protocols to characterize and modulate microRNA expression Methods Mol Biol 1220 2015 287 304
38. D.E. Kuhn, M.M. Martin, D.S. Feldman, and et al. Experimental validation of miRNA targets Methods 44 2008 47 54
39. Y. Huang, M. Crawford, N. Higuita-Castro, and et al. miR-146a regulates mechanotransduction and pressure-induced inflammation in small airway epithelium FASEB J 26 2012 3351 3364
40. M. Montano MicroRNAs: miRRORS of health and disease Transl Res 157 2011 157 162
41. W. Zhang, T. Zhou, S.F. Ma, and et al. MicroRNAs implicated in dysregulation of gene expression following human lung transplantation Transl Respir Med 1 2013
42. Y. Liang, D. Ridzon, L. Wong, and et al. Characterization of microRNA expression profiles in normal human tissues BMC Genomics 8 2007 166
43. H. Julich, A. Willms, V. Lukacs-Kornek, and et al. Extracellular vesicle profiling and their use as potential disease specific biomarker Front Immunol 5 2014 413
44. Z. Xu, D. Nayak, E. Trulock, and et al. OR15 De novo development of DSA following human lung transplantation is associated with changes on circulating micro-RNA involved in T and B cell regulation and fibrogenesis Hum Immunol 76 2015 13
45. Z. Xu, D. Nayak, W. Yang, and et al. Dysregulated MicroRNA expression and chronic lung allograft rejection in recipients with antibodies to donor HLA Am J Transplant 15 2015 1933 1947
46. Z. Xu, S. Ramachandran, M. Gunasekaran, and et al. MicroRNA-144 dysregulates the transforming growth factor-beta signaling cascade and contributes to the development of bronchiolitis obliterans syndrome after human lung transplantation J Heart Lung Transplant 34 2015 1154 1162
47. X. Ji, B. Wu, J. Fan, and et al. The anti-fibrotic effects and mechanisms of microRNA-486-5p in pulmonary fibrosis Sci Rep 5 2015 14131
48. M. Dong, X. Wang, H.L. Zhao, and et al. Integrated analysis of transcription factor, microRNA and LncRNA in an animal model of obliterative bronchiolitis Int J Clin Exp Pathol 8 2015 7050 7058
49. Y. Zhou, M. Xiong, L. Fang, and et al. miR-21-containing microvesicles from injured tubular epithelial cells promote tubular phenotype transition by targeting PTEN protein Am J Pathol 183 2013 1183 1196
50. L. Wei, X. Gong, O.M. Martinez, and et al. Differential expression and functions of microRNAs in liver transplantation and potential use as non-invasive biomarkers Transpl Immunol 29 2013 123 129
51. Z.B. Han, L. Zhong, M.J. Teng, and et al. Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation Mol Oncol 6 2012 445 457
52. K. Sugimachi, T. Matsumura, H. Hirata, and et al. Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation Br J Cancer 112 2015 532 538
53. A. Harris, S.M. Krams, and O.M. Martinez MicroRNAs as immune regulators: implications for transplantation Am J Transplant 10 2010 713 719
54. J.M. Lorenzen, and et al. Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients Am J Transplant 11 2011 2221 2227
55. D. Anglicheau, V.K. Sharma, R. Ding, and et al. MicroRNA expression profiles predictive of human renal allograft status Proc Natl Acad Sci USA 106 2009 5330 5335
56. E. Wang, Y. Nie, Q. Zhao, and et al. Circulating miRNAs reflect early myocardial injury and recovery after heart transplantation J Cardiothorac Surg 8 2013 165
57. L.N. Van Aelst, G. Summer, S. Li, and et al. RNA Profiling in human and murine transplanted hearts: identification and validation of therapeutic targets for acute cardiac and renal allograft rejection Am J Transplant 16 2015 99 110
58. J. Lu, J. Qian, F. Chen, and et al. Differential expression of components of the microRNA machinery during mouse organogenesis Biochem Biophys Res Commun 334 2005 319 323
59. A. Sittka, and B. Schmeck MicroRNAs in the lung Adv Exp Med Biol 774 2013 121 134
60. R.C. Friedman, K.K. Farh, C.B. Burge, and et al. Most mammalian mRNAs are conserved targets of microRNAs Genome Res 19 2009 92 105
61. D. Grun, Y.L. Wang, D. Langenberger, and et al. microRNA target predictions across seven Drosophila species and comparison to mammalian targets PLoS Comput Biol 1 2005 e13
62. K.S. Harris, Z. Zhang, M.T. McManus, and et al. Dicer function is essential for lung epithelium morphogenesis Proc Natl Acad Sci USA 103 2006 2208 2213
63. M. Fabbri, R. Garzon, A. Cimmino, and et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B Proc Natl Acad Sci USA 104 2007 15805 15810
64. G. Carraro, A. El-Hashash, D. Guidolin, and et al. miR-17 family of microRNAs controls FGF10-mediated embryonic lung epithelial branching morphogenesis through MAPK14 and STAT3 regulation of E-cadherin distribution Dev Biol 333 2009 238 250
65. A. Rodriguez, E. Vigorito, S. Clare, and et al. Requirement of bic/microRNA-155 for normal immune function Science 316 2007 608 611
66. E. Sonkoly, M. Stahle, and A. Pivarcsi MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation Semin Cancer Biol 18 2008 131 140
67. B.S. Lu, A.D. Yu, X. Zhu, and et al. Sequential gene expression profiling in lung transplant recipients with chronic rejection Chest 130 2006 847 854
68. A. Szczepankiewicz, P.M. Lackie, and J.W. Holloway Altered microRNA expression profile during epithelial wound repair in bronchial epithelial cells BMC Pulm Med 13 2013 63
69. A.G. Bader miR-34 - a microRNA replacement therapy is headed to the clinic Front Gene 3 2012 120
70. I.P. Pogribny, A. Starlard-Davenport, V.P. Tryndyak, and et al. Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice Lab Invest 90 2010 1437 1446
71. M.M. Perry, S.A. Moschos, A.E. Williams, and et al. Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells J Immunol 180 2008 5689 5698
72. Y. Huang, M. Crawford, N. Higuita-Castro, and et al. miR-146a regulates mechanotransduction and pressure-induced inflammation in small airway epithelium FASEB J 26 2012 3351 3364
73. G. Chen, I.A. Umelo, S. Lv, and et al. miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells PLoS One 8 2013 e60317
74. S. Vettori, S. Gay, and O. Distler Role of MicroRNAs in fibrosis Open Rheumatol J 6 2010 130 139
75. G. Liu, A. Friggeri, Y. Yang, and et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis J Exp Med 207 2010 1589 1597
76. S. Ladak, C. Ward, and S. Ali MicroRNA-200B represses TGF-beta 1 induced EMT in BEAS-2B and primary bronchial epithelial cells Thorax 70 2015 A68
77. Y. Cai, X. Yu, S. Hu, and et al. A brief review on the mechanisms of miRNA regulation Genom Proteom Bioinform 7 2009 147 154
78. A. Kishore, J. Borucka, J. Petrkova, and et al. Novel insights into miRNA in lung and heart inflammatory diseases Mediators Inflamm 2014 2014 259131
79. J. Zhang, and L. Ma MicroRNA control of epithelial-mesenchymal transition and metastasis Cancer Metastasis Rev 31 2012 653 662
80. A.G. Bader, D. Brown, and M. Winkler The promise of microRNA replacement therapy Cancer Res 70 2010 7027 7030
81. R.L. Montgomery, G. Yu, P.A. Latimer, and et al. MicroRNA mimicry blocks pulmonary fibrosis EMBO Mol Med 6 2014 1347 1356
82. D. Barh, R. Malhotra, B. Ravi, and et al. MicroRNA let-7: an emerging next-generation cancer therapeutic Curr Oncol 17 2010 70 80
83. C.L. Jopling, M. Yi, A.M. Lancaster, and et al. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA Science 309 2005 1577 1581
84. R.E. Lanford, E.S. Hildebrandt-Eriksen, A. Petri, and et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection Science 327 2010 198 201
85. E. van Rooij, L.B. Sutherland, X. Qi, and et al. Control of stress-dependent cardiac growth and gene expression by a microRNA Science 316 2007 575 579
86. X.Y. You, J.H. Huang, B. Liu, and et al. HMGA1 is a new target of miR-195 involving isoprenaline-induced cardiomyocyte hypertrophy Biochemistry (Mosc) 79 2014 538 544
87. V.R. Mas, C.I. Dumur, M.J. Scian, and et al. MicroRNAs as biomarkers in solid organ transplantation Am J Transplant 13 2013 11 19
88. D.S. Bedi, L.V. Riella, S.G. Tullius, and et al. Animal models of chronic allograft injury: contributions and limitations to understanding the mechanism of long-term graft dysfunction Transplantation 90 2010 935 944
89. R. Garzon, G. Marcucci, and C.M. Croce Targeting microRNAs in cancer: rationale, strategies and challenges Nat Rev Drug Discov 9 2010 775 789
90. Z. Li, and T.M. Rana Therapeutic targeting of microRNAs: current status and future challenges Nat Rev Drug Discov 13 2014 622 638
91. H. Baigude, and T.M. Rana Strategies to antagonize miRNA functions in vitro and in vivo Nanomedicine (Lond) 9 2014 2545 2555
92. G. Hu, K.M. Drescher, and X.M. Chen Exosomal miRNAs: biological properties and therapeutic potential Front Genet 3 2012 56
93. J. Saikumar, D. Hoffmann, T.M. Kim, and et al. Expression, circulation, and excretion profile of microRNA-21, -155, and -18a following acute kidney injury Toxicol Sci 129 2012 256 267
94. J.P. Van Huyen, M. Tible, A. Gay, and et al. MicroRNAs as non-invasive biomarkers of heart transplant rejection Eur Heart J 35 2014 3194 3202
95. E. Wang, Y. Nie, Q. Zhao, and et al. Circulating miRNAs reflect early myocardial injury and recovery after heart transplantation J Cardiothorac Surg 8 2013 165
96. W.R. Farid, Q. Pan, A.J. van der Meer, and et al. Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation Liver Transpl 18 2012 290 297
97. A. Kishore, J. Borucka, J. Petrkova, and et al. Novel insights into miRNA in lung and heart inflammatory diseases Mediators Inflamm 2014 2014 259131
98. C. Huang, X. Xiao, N.R. Chintagari, and et al. MicroRNA and mRNA expression profiling in rat acute respiratory distress syndrome BMC Med Genomics 7 2014 46
99. C.S. Neal, M.Z. Michael, L.K. Pimlott, and et al. Circulating microRNA expression is reduced in chronic kidney disease Nephrol Dial Transplant 26 2011 3794 3802
100. M. Kato, L. Arce, and R. Natarajan MicroRNAs and their role in progressive kidney diseases Clin J Am Soc Nephrol 4 2009 1255 1266
101. F. Trevisani, M. Ghidini, P. Manunta, and et al. SP299MICRORNA-200B as predictive biomarker of chronic kidney disease (CKD) in patients undergoing radical nephrectomy Nephrol Dial Transplant 2015 30:iii478
102. Y. Goren, M. Kushnir, B. Zafrir, and et al. Serum levels of microRNAs in patients with heart failure Eur J Heart Fail 14 2012 147 154
103. K. Endo, Y. Naito, X. Ji, and et al. MicroRNA 210 as a biomarker for congestive heart failure Biol Pharm Bull 36 2013 48 54
104. C. Roderburg, G.W. Urban, K. Bettermann, and et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis Hepatology 53 2011 209 218
105. S. Cermelli, A. Ruggieri, J.A. Marrero, and et al. Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease PLoS One 6 2011 e23937
106. M. Angulo, E. Lecuona, and J.I. Sznajder Role of MicroRNAs in lung disease Arch Bronconeumol 48 2012 325 330
107. H. Liang, Y. Gu, T. Li, and et al. Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis Cell Death Dis 5 2014 e1238